Robert Hubbard
15Patents
4h-index
61Co-inventors
63Inventor score
Filing activity: May 10, 2000 → Jan 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7772231B2 | Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors | Human Necessities | 62 | Active |
| US9512124B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 24 | Active |
| US9737541B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 9 | Active |
| US7812022B2 | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors | Human Necessities | 5 | Active |
| US7807673B2 | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors | Human Necessities | 4 | Active |
| US10398700B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 2 | Active |
| US9561231B2 | Pyridinone and pyridazinone derivatives | Chemistry; Metallurgy | 2 | Active |
| US10149849B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 2 | Active |
| US10646493B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US9493411B2 | Pyrrole-3-carboxamide bromodomain inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10940152B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US6562782B1 | Oligocycloalkanoid compounds and methods of use | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11590139B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US8067409B2 | Protein kinase inhibitors | Human Necessities | 0 | Active |
| US10576085B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.